Andrew Wei, MBBS, PhD, is a Victorian Cancer Agency Research Fellow and Haematologist who conducts clinical and translational AML research through dual appointments at the Alfred Hospital and Monash University.
After completing doctoral studies at the Walter and Eliza Hall Institute of Medical Research, he joined the Alfred Hospital to develop the AML research program.
Dr Wei is an executive member of the Australasian Leukaemia and Lymphoma Group (ALLG) Scientific Advisory Committee, a member of the National Medical and Scientific Advisory Committee of the Leukaemia Foundation of Australia and Head of Leukaemia Research at the Alfred hospital. He sits on the International Steering Committee for Celgene providing expert advice on AML.
To enhance translational research, Dr Wei has established the Alfred Haematology Tissue Bank, the diagnostic molecular haematology laboratory and a pre-clinical research laboratory to focus on the role of targeting survival pathways in AML.
Dr Wei’s research focuses on the mechanisms by which cancer cells co-opt and coerce intracellular signalling pathways to promote deregulated cell survival, proliferation and growth. Through the molecular analysis of intracellular signalling pathways, his laboratory seeks to identify new therapeutic targets in leukaemia.